share_log

復星醫藥：非登記股東之通知信函及申請表格

FOSUN PHARMA: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

Hong Kong Stock Exchange ·  Apr 24 16:49
Summary by Futu AI
上海復星醫藥（集團）股份有限公司於2024年4月24日向非登記H股股東發出通知，公告其2023年年報已可在公司及香港聯合交易所有限公司網站上獲得。股東若需印刷版年報，可填妥申請表格並透過郵件或電子郵件方式回傳給H股股份過戶登記處卓佳證券登記有限公司。公司提供了詳細的聯絡資訊及申請指南，以便股東能夠方便地索取相關文件。
上海復星醫藥（集團）股份有限公司於2024年4月24日向非登記H股股東發出通知，公告其2023年年報已可在公司及香港聯合交易所有限公司網站上獲得。股東若需印刷版年報，可填妥申請表格並透過郵件或電子郵件方式回傳給H股股份過戶登記處卓佳證券登記有限公司。公司提供了詳細的聯絡資訊及申請指南，以便股東能夠方便地索取相關文件。
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. ISSUED A NOTICE ON 24 APRIL 2024 TO NON-REGISTERED H SHAREHOLDERS ANNOUNCING THAT ITS 2023 ANNUAL REPORT IS AVAILABLE ON THE COMPANY'S WEBSITE AND ON THE HKEX LIMITED WEBSITE. If shareholders require a printed annual report, they may complete the application form and send it back to the H Share Transfer Registry, Chujia Securities Registry Limited by mail or e-mail. The Company provides detailed contact information and application guidance so that shareholders can easily request relevant documents.
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. ISSUED A NOTICE ON 24 APRIL 2024 TO NON-REGISTERED H SHAREHOLDERS ANNOUNCING THAT ITS 2023 ANNUAL REPORT IS AVAILABLE ON THE COMPANY'S WEBSITE AND ON THE HKEX LIMITED WEBSITE. If shareholders require a printed annual report, they may complete the application form and send it back to the H Share Transfer Registry, Chujia Securities Registry Limited by mail or e-mail. The Company provides detailed contact information and application guidance so that shareholders can easily request relevant documents.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.